do it right, go down in historyVolume will dictate price, the more the order volume the lower per unit the cost. Outsourcing is obvious, but the repeat business and the future business with other detection tests will be in demand from this new technology. You may be underrating the scope this company may have through its patents, it may tank on hype but I think we are now getting past that point, or be bought out at $60+ or anything in between. It is all a guess on supply and demand, and I think the demand for a product that is reliable and affordable to identify these pathogens is unique and its time has come, no more guessing, people deserve more than these existing faulty tests, this may make history if done slowly and correctly, that is why I am here investing, IMO.